These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34407307)

  • 1. Current status and future directions of clinical applications using iPS cells-focus on Japan.
    Tsujimoto H; Osafune K
    FEBS J; 2022 Dec; 289(23):7274-7291. PubMed ID: 34407307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iPS cell technologies: significance and applications to CNS regeneration and disease.
    Okano H; Yamanaka S
    Mol Brain; 2014 Mar; 7():22. PubMed ID: 24685317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells.
    Rami F; Beni SN; Kahnamooi MM; Rahimmanesh I; Salehi AR; Salehi R
    Cell Reprogram; 2017 Apr; 19(2):65-74. PubMed ID: 28266864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present and Future of an iPS Cell Stock for Regenerative Medicine].
    Hanatani T; Takasu N
    Rinsho Byori; 2017 Feb; 65(2):160-166. PubMed ID: 30762982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies.
    Yamashita T; Takayama K; Hori M; Harada-Shiba M; Mizuguchi H
    Biol Pharm Bull; 2019; 42(3):312-318. PubMed ID: 30828061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and Industrialization of a New Treatment Method Using Regenerative Cardiomyocyte Transplantation for Refractory Severe Heart Failure - Secondary Publication.
    Fukuda K
    JMA J; 2023 Oct; 6(4):388-392. PubMed ID: 37941693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine.
    Ebben JD; Zorniak M; Clark PA; Kuo JS
    World Neurosurg; 2011; 76(3-4):270-5. PubMed ID: 21986423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-induced pluripotent stem cells: in quest of clinical applications.
    Madonna R
    Mol Biotechnol; 2012 Oct; 52(2):193-203. PubMed ID: 22302314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinal Cell Therapy Using iPS Cells].
    Takahashi M
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):210-24; discussion 225. PubMed ID: 27164758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Future Innovative Medicine for Corneal Diseases].
    Nishida K
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):226-44; discussion 245. PubMed ID: 27164759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10th anniversary of iPS cells: the challenges that lie ahead.
    Aoi T
    J Biochem; 2016 Sep; 160(3):121-9. PubMed ID: 27387749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Therapy Using Induced Pluripotent Stem (iPS) Cells Meets Next-Next Generation DNA Sequencing Technology.
    Nakayama M
    Curr Genomics; 2009 Aug; 10(5):303-5. PubMed ID: 20119527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How induced pluripotent stem cells are redefining personalized medicine.
    Ferreira LM; Mostajo-Radji MA
    Gene; 2013 May; 520(1):1-6. PubMed ID: 23470844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine.
    Deguchi S; Takayama K; Mizuguchi H
    Biol Pharm Bull; 2020; 43(4):608-615. PubMed ID: 32238703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of iPS cells in advancing regenerative medicine.
    Liu P; Li KE; Xu S
    Genet Res (Camb); 2016 Feb; 98():e4. PubMed ID: 26864234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone and Stem Cells. Advancement of regenerative medicine in the locomotive system using iPS cells].
    Toguchida J
    Clin Calcium; 2014 Apr; 24(4):587-92. PubMed ID: 24681505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.